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Abstract
Background: Sequencing-based analysis has become a well-established approach to deciphering the composition
of the gut microbiota. However, due to the complexity of accessing sufficient material from colonoscopic biopsy
samples, most studies have focused on faecal microbiota analysis, even though it is recognised that differences
exist between the microbial composition of colonic biopsies and faecal samples. We determined the suitability of
colonic lavage samples to see if it had comparable microbial diversity composition to colonic biopsies as they are
without the limitations associated with sample size. We collected paired colonic biopsies and lavage samples from
subjects who were attending for colorectal cancer screening colonoscopy.
Results: Next-generation sequencing and qPCR validation were performed with multiple bioinformatics analyses to
determine the composition and predict function of the microbiota. Colonic lavage samples contained significantly
higher numbers of operational taxonomic units (OTUs) compared to corresponding biopsy samples, however,
diversity and evenness between lavage and biopsy samples were similar. The differences seen were driven by the
presence of 12 OTUs which were in higher relative abundance in biopsies and were either not present or in low
relative abundance in lavage samples, whilst a further 3 OTUs were present in higher amounts in the lavage
samples compared to biopsy samples. However, predicted functional community profiling based on 16S ribosomal
ribonucleic acid (rRNA) data indicated minimal differences between sample types.
Conclusions: We propose that colonic lavage samples provide a relatively accurate representation of biopsy
microbiota composition and should be considered where biopsy size is an issue.
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Background
The importance of the gut microbiome in human health
and disease is unequivocal. Humans have evolved over
millennia to develop this complex ecosystem of micro-
organisms, which provides critical health benefits
including regulation of the immune system, metabolic
processes and homeostatic control [1–3]. Disruption of
this stable microbial balance has been associated with a
wide range of disease states including inflammatory
bowel disease [4–6] and colorectal cancer [7–9] as well
as a number of extra-intestinal conditions including
obesity [10–12], diabetes [13, 14], liver disease [15] and
autoimmune conditions [16, 17].
Despite major advances in microbiological research
over the past two decades, there are still fundamental
imperfections with sampling techniques that must be
addressed and refined [18–20]. Although the majority
of studies have assessed gut microbial diversity through
analysis of faecal samples, their ability to reflect microbial
diversity at the mucosal surface is inadequate [21–23].
Mucosal biopsies display greater microbial diversity than
faecal samples [24] as well as taxonomic and phylogenetic
differences [25] and contrasting dominant bacterial popu-
lations [22]. Colonic mucosal biopsies have always been
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regarded as the sampling gold standard, but there is a
limit to how this approach could cope with the competing
demands for different starting material (DNA, RNA and
proteins) required for modern multi-omic technologies.
Given the limitations of available biopsy material and
the known differences between faecal and biopsy micro-
bial communities, we set out to investigate whether co-
lonic lavage was an alternative approach that could
provide a comparable assessment of microbial diversity
without the limitations associated with biopsy collection.
We collected paired sigmoid colonic mucosal biopsies
and lavage samples from patients attending for colonos-
copy and performed a comprehensive assessment of mi-
crobial diversity using 16S ribosomal ribonucleic acid
(rRNA) gene sequencing. Our data indicate that colonic
lavage samples yield significantly higher amounts of
DNA whilst also containing higher microbial counts
compared to corresponding biopsy samples although di-
versity and evenness are similar. Differences between
sample types were driven by a limited number of OTUs,
which were generally over-represented in biopsies and
absent or in lower relative abundance in colonic lavage
samples. This difference in diversity corresponded with
limited differences in the predicted functional profile
highlighting that colonic lavage could be considered for
colonic microbial diversity studies where multiple omic
analyses are required as colonic lavage samples are not
as limited as mucosal biopsies.
Results
Paired samples (biopsy (Bx) and colonic lavage (CL))
were collected from 23 participants attending for colo-
rectal cancer screening colonoscopy, but with no evidence
of pathology seen during colonoscopy examination and
subsequent histological analysis which was performed on
all participants. Subjects were attending for colonoscopy
due to a positive faecal occult blood test but were other-
wise asymptomatic and had not taken antibiotics in
6 months prior to colonoscopy. Average age of the sub-
jects was 59.9 years (range 50–75 years), and there was an
even split of males and females (Table 1). All participants
were from the North East of Scotland and were Caucasian.
No information was recorded relating to pro- or prebiotic
usage. All participants underwent a similar bowel
cleansing procedure. Bowel preparation was good in all
subjects in the study. DNA yields were significantly
higher from colonic lavage samples compared to that of
biopsies, with median DNA yields of 48.5 μg (interquar-
tile range [IQR] 34.5–66.8) for colonic lavage samples
and 1.95 μg ([IQR] 1.53–4.3) for biopsies (p < 0.0001;
Additional file 1: Fig. S1).
A total of 3,196,431 16S rRNA sequence reads was
obtained following quality filtering, equating to 69487 ±
4907 (mean ± SEM) reads per sample. After the removal
of chimeras (12.37%) and non-bacterial sequences
(12.38%), the number of mapped sequence reads, per
sample, ranged from 11879 to 94103 (mean ± SEM of
60886 ± 4034) (Additional file 2: Table S1). Following the
removal of rare OTUs, defined as OTUs with 2 or less
sequences across all the samples, which reduced the ini-
tial 131669 OTUs down to 17524, rarefaction analysis
demonstrated sufficient sequencing depth (Additional
file 3: Fig. S2). After removal of rare OTUs, a total of
2,672,954 sequences, equating to 58107 ± 3831 (mean ±
SEM) reads per sample remained. A total of 127803
rare sequences was removed, equating to 2778 ± 217
(mean ± SEM) reads per sample.
Alpha diversity metrics
The effect of sample type (colonic lavage vs biopsy) on
alpha diversity was assessed based on OTU richness
(measured based on the absolute number of taxa), diver-
sity and evenness (Fig. 1). OTU richness differed signifi-
cantly between biopsy and lavage sample sets with
increased richness present in the lavage samples
depicted through Observed OTUs, Chao and Good’s
coverage analysis (p < 0.0001, all analyses, Mann-Whitney
U test; Fig. 1a, b and e). However, even with differing
numbers of OTUs, the diversity and evenness between
colonic lavage and biopsy samples were similar, which
was demonstrated by Shannon and inverse Simpson’s
scores (Fig. 1c, d).
Relative abundance analysis
The dominant phyla across all samples were Firmicutes
(median relative abundance, 45.46%; IQR 36.67%,
55.20%), Bacteroidetes (43.43%; IQR 37.57%, 50.71%),
Proteobacteria (3.45%; IQR 1.65%, 5.92%) and Actinobac-
teria (0.47%; IQR 0.24%, 0.79%; Fig. 2). The relative
abundance of these four phyla did not differ significantly
based on sample type (p > 0.05, Wilcoxon rank-sum test;
Table 2). qPCR analysis of samples was performed to
validate the sequencing approach. Correlation between
Illumina sequence data and qPCR data generated R2
values of 0.86, 0.88, 0.81 and 0.95 for Bacteroidaceae,
Lachnispiraceae, Ruminococcaceae and Enterobacteria-
ceae, respectively (Additional file 4: Fig. S3 and Additional
file 5). Biopsy and lavage samples did not form discrete
Table 1 Study cohort information
Cohort metadata
Number of patients (N) 23
Gender (% M:F) 48:52
Average age, in years, at procedure ± SD (range) 59.9 ± 7.9 (50, 75)
Antibiotic use within the previous 6 months 0
Sample location (%)
Sigmoid colon 100
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clusters by family. Paired subject samples (Bx and CL) of
16 subjects formed distinct clusters at the family level
(Fig. 3). Four of the 16 paired subject samples clusters
were highly supported by the data with approximately
unbiased (AU) p values > 95 (Additional file 6: Fig. S4a).
The AU p values of the other paired subject samples
clusters ranged from 58 to 94 with only one below 71.
Microbiota ordination and taxon distribution
Principal coordinate analysis (PCoA) of Jaccard and Yue
& Clayton distance measures revealed that samples did
not cluster strongly by subject. Some paired subject sam-
ples (Bx and CL) did cluster together with regards to
OTU richness and OTU community structure (Fig. 4a, b).
However, the distances between biopsy and lavage samples
were still quite large especially for the Jaccard distances
(Fig. 4a). The PCoA plot for Jaccard distances does how-
ever demonstrate that the relative direction between the
lavage and biopsy sample from the same subject was simi-
lar. This may indicate that specific OTUs are shared by
the biopsy samples that are not present in lavage samples
and vice versa. The picture was less clear with the PCoA
plot for Yue & Clayton with no strong clustering by indi-
viduals or sample type (Fig. 4b). There appears to be no
pattern of shift from the colonic lavage and biopsy sam-
ples from the same individual. Consistent with these find-
ings, an AMOVA (analysis of molecular variance) test on
the Jaccard dissimilarity matrices indicated that sample
type contributed significantly to the differences in micro-
bial composition of the samples (AMOVA p = 0.001).
It was found that the Jaccard and Yue & Clayton
paired distances of biopsy and lavage samples within
participants (e.g. Bx1-CL1, Bx2-CL2, Bx3-CL3) were sig-
nificantly smaller than all the paired distances of all the
samples between participants (e.g. Bx1-Bx2, Bx1-CL2,
Bx1-Bx3, Bx1-CL3), the paired distances between all the
Fig. 1 Species diversity comparison between colonic biopsy and lavage sample. The extent of microbiota structural and composition diversities
were measured using (a) Observed OTUs and (b) Chao (species richness), (c) Shannon-Weiner diversity index, (d) inverse Simpson’s evenness
index and (e) Good’s coverage (species richness). Alpha diversity scores calculated by subsampling samples to 11000 reads with 1000 iterations.
Each point represents the diversity score for a patient sample. Error bars represent SEM. Between-group variations were measured using Mann-Whitney
U test. P values of Mann-Whitney U test for each alpha diversity measure are below the relevant facet
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biopsy samples (e.g. Bx1-Bx2, Bx1-Bx3, Bx1-Bx4), the
paired distances between all the biopsy and all the lavage
samples (e.g. Bx1-CL1, Bx1-CL2, Bx1-CL3) and the
paired distances between all the lavage samples (e.g.
CL1-CL2, CL1-CL3, CL1-CL4) (Fig. 4c, d, p value < 0.05
for t test of unequal variance). The Jaccard paired dis-
tances of biopsy and lavage samples within participants
were relatively high and similar to the other comparisons
(Fig. 4c). The Yue & Clayton paired distances of biopsy
and lavage samples within participants were very varied
with relatively low values for the 25th and 75th percen-
tiles, ~0.5 and ~0.8 (Fig. 4d). This shows that some of
the Bx and CL paired samples of certain participants
had more similar communities than within other partici-
pants. Overall, these results indicate that intra-participant
(within) OTU richness similarities are not much greater
compared to that of intra-participant (between) samples.
However, community structure similarities are much
biopsy lavage
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Fig. 2 Relative abundance at phylum level for colonic biopsy and lavage samples
Table 2 Mean difference in the relative abundance of the phyla Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria. P value
based on Wilcoxon rank-sum test
Phylum Mean relative abundance ± SEM Difference in mean relative abundance ± SEM
Biopsy Lavage p value
Firmicutes 46.51 ± 3.81 50.19 ± 3.45 3.68 ± 0.36 0.65
Bacteroidetes 43.18 ± 3.04 40.43 ± 3.43 2.75 ± 0.39 1.00
Proteobacteria 5.06 ± 0.78 3.83 ± 0.87 1.23 ± 0.09 0.11
Actinobacteria 0.52 ± 0.08 1.43 ± 0.63 0.91 ± 0.55 0.23
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higher for the inter-participant samples than that of intra-
participant samples.
Correlation
Spearman correlation was carried out to compare the
different sample types. This was performed on sample
OTU sets after removal of rare OTUs (defined as
OTUs with two or less sequences across all the sam-
ples) (Fig. 5). Overall, most of the biopsy samples’
highest positive correlation was with its reciprocal
lavage sample and vice versa. However, these correla-
tions were small and there were significant, but small,
correlations found between the majority of CL and
Bx samples.
Fig. 3 The distribution of bacteria in colonic biopsy and lavage samples at family level. Heat maps show Log2count of sequences within each classification
level. Two sets of colours on the column caps: red/blue depicts sample type (red= lavage (CL), blue=biopsy (Bx)). Multicolour panel reflects individual subjects
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Fig. 4 Beta diversity comparisons. Clustering of samples according to sample type (colonic biopsy and lavage) by PCoA, based on (a) Jaccard and
(b) Yue & Clayton similarity distances, and box plots of paired samples’ similarity distances, based on (c) Jaccard and (d) Yue & Clayton. Within the
PCoA plots, loadings of the three axes sum up to 9.35 and 24.86%. Colonic biopsy and lavage samples from the same individual are connected
together. Each subject is depicted in a unique colour, and colonic biopsy points are depicted as triangles whilst lavage samples are circles. Within
the box plots, Bx-Bx refers to all pairs of biopsy samples, Bx-CL refers to all biopsy and lavage sample pairs, CL-CL refers to all pairs of lavage
samples, inter-participant refers to all pairs of samples between participants, and intra-participant refers to all pairs of samples within participants
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Group significance test
Linear discriminant analysis effect size (LEfSe) analysis
was carried out to determine which OTUs were driving
the differences between sample types. These analyses
showed that 12 OTUs were present within the biopsy
samples that are either not present or in much lower
amounts in the lavage samples (Fig. 6a; Additional file 7:
Table S2). A further 3 OTUs were present in higher
amounts in the lavage samples compared to biopsy sam-
ples. Collectively, these 15 OTUs constituted 1.36% of the
sequences derived (Table 3). A number of these OTUs rep-
resent bacterial species that have been identified as contam-
inating sequences in previous PCR-based sequencing
studies [26]. Streptococcus, Propionibacterium, Acinetobac-
ter and Comamonas were all reported to be potentially con-
taminants with Streptococcus and Propionibacterium being
common human skin-associated organisms and were in
higher relative abundance in biopsy samples compared to
that of lavage samples. Hierarchical clustering based on
these 15 OTUs demonstrated robust separation by individ-
ual subjects in 20/23 cases (87%; Fig. 6b). Many of the clus-
ters were highly supported by the data with 14 of the
CL samples and 9 of the Bx samples within highly
supported clusters (AU p value > 95) that separate the
majority of Bx and CL samples and all other AU p values
ranging from 68 to 95 (Additional file 6: Fig. S4b).
Producing a heat map of the top 50 OTUs (which
comprised 14.65% of total reads) and excluded OTUs
found to be differentially abundant by sample type,
showed strong separate clusters formed for most sub-
jects (Table 4; Additional file 8: Table S3). The only sub-
jects whose paired samples did not form separate
clusters were subjects 2, 9, 10 and 12 (Fig. 7). Of the 19
paired subject samples that formed distinct clusters by
hierarchical clustering, 17 clusters were highly supported
(AU p value > 95) (Additional file 6: Fig. S4c).
Contaminant genera assessment
Laboratory contaminants have been shown to affect the
results of 16S rRNA samples with low biomass [26]. Gen-
era that were determined to be possible laboratory con-
taminants were searched for in our dataset. Thirty-three
of these genera were detected in the biopsy samples whilst
11 were discovered in the lavage samples with an overlap
of 10 genera. These genera were found in higher relative
abundances within the biopsy samples compared to the
lavage samples (Additional file 9: Fig. S5). A low percent-
age of the total QC sequences matched these genera with
Fig. 5 Spearman correlation plot of biopsy against lavage samples using OTU counts. Spearman correlations with non-significant p values (>0.05)
were excluded
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Fig. 6 Differentially abundant OTUs between biopsy and lavage samples by LefSe. a LEfSe LDA scores. b Heat map of Log2count of OTUs.
Colours on the column caps depict sample type (red = lavage (CL), blue = biopsy (Bx)). OTUs were labelled by their genera
Table 3 Information regarding the 15 OTUs detected as biomarkers by LEfSe. Table shows the average amount of reads, average
relative abundance and percentage of sequences compared to the total amount of sequences
Count average SEM Average relative abundance SEM % of total reads SEM
All 790.76 121.89 0.0223 0.0057 1.3609 0.0046
Biopsy 803.04 158.75 0.0345 0.0107 0.6910 0.0059
Lavage 778.48 188.59 0.0101 0.0025 0.6699 0.0071
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the biopsy and lavage sequences matching these making
up 0.35 and 0.59% of the total QC reads.
Assessment of biopsy and colonic lavage microbial
community function
In order to understand the functional differences between
communities within biopsies and colonic lavage samples
and their relation to community composition, we used
phylogenetic investigation of communities by reconstruc-
tion of unobserved states (PICRUSt) [27] to infer commu-
nity metabolic potential (Additional file 5), then used
LEfSe [28] to identify functions that differed significantly
between sample types.
Very limited functional differences based on kyoto
encyclopedia of genes and genomes (KEGG) pathways
were seen between biopsy and colonic lavage samples
(Additional file 10: Fig. S6a). The three KEGG pathways,
pyruvate metabolism, translation proteins and valine,
leucine and isoleucine biosynthesis, were found to be in
higher relative abundance in colonic lavage samples
(Additional file 10: Fig. S6c). One KEGG pathway, the
two-component regulatory system, was found to be in
higher relative abundance in biopsy samples. The two-
component system was shown to have a larger effect size
with which it differentiated between the two sample
types, compared to the other differential KEGG pathways,
with a larger log10 LDA score. Alpha and beta diversity
analysis for the predicted KEGG pathways, produced by
PICRUSt, were carried out. For alpha diversity the main
difference was the higher amount of observed pathways
and predicted pathways but difference by coverage was
minimal (Additional file 10: Fig. S6b). For beta diversity
there was limited evidence of difference between the
paired colonic lavage and biopsy samples. Axes one and
two did not show a pattern of shift between the biopsy
and lavage paired samples, however, axis three showed
some differences but with very small axes lengths indicat-
ing the differences observed were small (Fig. 8).
Discussion
Understanding the role of the gut microbiota in disease
development is a constantly moving field and as next-
generation sequencing approaches become more available
we embrace the potential of leveraging multiple omics
datasets from a single sample type. The limitations of
available biopsy sample size are becoming apparent
[29]. Currently, there are no effective experimental
approaches that allow retention of pristinely represen-
tative DNA, RNA, proteins and other metabolic frac-
tions from limited biopsy samples, in sufficient yield,
meaning that scientific aspirations are hampered by
clinical sample availability, which is a role reversal from
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a decade ago when technological capabilities were the
bottleneck.
This study is one of the first successful attempts to
seek a suitable alternative sample type, namely, colonic
lavage, as a reproducible replacement to colonic mucosal
biopsies for the purposes of studying the gut microbiome.
We comprehensively examined microbial composition
and predicted function of patient matched colonic biop-
sies and lavage samples within 23 individuals. All samples
were collected from subjects who had undergone bowel
preparation, which may alter microbial alpha and beta
diversity [30–32]. However, we reason that all patients
were subjected to the same bowel cleansing regime there-
fore were subjected to the same introduced bias. Patients
received bowel preparation the day before the procedure
in the form of Picolax. This laxative has two ingredients:
sodium picosulfate and magnesium citrate. The former is
a stimulant laxative and the latter is an osmotic laxative.
The preparation comes in powder form which is reconsti-
tuted in 150 ml of cold water before ingestion, and the
usual dose is two sachets taken 6 h apart the day prior to
the colonoscopy. The patients are encouraged to drink as
much clear fluids as possible on the day prior to the pro-
cedure to flush the bowel out. Patients were not asked to
collect this material as it is impractical, unpleasant and
logistically challenging, although this has been done in
previous studies, e.g. Jalanka et al. [33], using a different
laxative (Moviprep). As the colon is a large and capacious
tube, it can never be completely evacuated and inevitably
some liquid remains in the bowel. The remaining liquid is
therefore bathing the colonic mucosa and tends to shift
naturally around the bowel with the aid of peristalsis and
the constant changes in the movement and posture of the
subject (e.g. supine vs recumbent or semi-recumbent posi-
tions). This lavage fluid is often encountered at the time
of colonoscopy and is very easy to aspirate through a
suction channel in the colonoscope and directly into a
collecting tube. Both biopsies and colonic lavage samples
were collected simultaneously, lavage followed by biopsy,
therefore observed relationships are representative of ac-
curate comparisons between sample types and most likely
reflect the scope of the majority of such samples available
for collection for research studies.
Previous studies which looked at the effect of bowel
cleansing treatment have not demonstrated consistent
findings. Jalanka et al. [33] demonstrated a decrease in
the abundance of the members of Clostridium cluster IV
and increased the members of Clostridium cluster XIVa
Fig. 8 Clustering of samples’ PICRUSt predicted KEGG pathways according to sample type (colonic biopsy and lavage) by NMDS, based on Yue &
Clayton similarity distance. The R-squared configuration of the three axes was equal to 0.94413 with a lowest stress of 0.188611. Colonic biopsy
and lavage samples from the same individual are connected together. Each subject is depicted in a unique colour. Colonic biopsy points are
depicted as triangles, lavage samples are circles
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and Proteobacteria. Other studies identifying changes
caused by bowel cleansing include Harrell et al. [30],
O’Brien et al. [32], Mai et al. [34], Drago et al. [35] and
Jain et al. [36], whilst other studies have failed to demon-
strate changes [37–39]. The findings of the current study
are most relevant to the type of bowel preparation that
we used, i.e. Picolax and it is unknown whether other
types of bowel preparation would produce different re-
sults. It is likely that specific species/taxa will be affected
by the bowel prep itself. These questions should be an-
swered in a subsequent study designed to compare the
effects of different types of bowel preparation on the gut
microbiota. In the current study, our primary focus was
on using colonic lavage as a proxy for endoscopic co-
lonic biopsies and as such we sought to reduce potential
variation by sticking with one type of bowel preparation.
Knowing that bowel prep may affect microbial diver-
sity and introduce metabolic changes in the microbial
community, consideration should be given to assessing
the situation in unprepped colonic samples in future
studies. The most complete study would need to sample
faeces and the unprepped colon prior to bowel prep,
followed by additional sampling during prepped colon-
oscopy and additional faecal sampling post procedure.
This approach would provide unequivocal comparison
of the effectiveness of the various sample types available.
However, logistically such a study will be extremely chal-
lenging to conduct. A recent study looked at microbial
changes caused by bowel prep in both healthy subjects
and patients with IBD. Biopsy and faecal samples were
collected pre and post bowel prep but longitudinal faecal
follow up was not undertaken. The study demonstrated
that bowel prep affected the composition and diversity
of the microbiota in the short term differently between
sample types with differences also noted between con-
trols and IBD patients. Biopsies from healthy subjects
showed greater changes due to bowel prep compared to
IBD patients [40].
This study revealed surprising overlap between com-
munity composition and function in paired biopsy and
colonic lavage samples. This is in contrast to previous
studies that have assessed the suitability of faecal sam-
ples as an alternative to biopsies for defining microbial
diversity at the mucosal surface and have demonstrated
significant differences [21–25, 41, 42]. The fact that
PICRUSt analysis did not demonstrate differences be-
tween (a) biopsy and colonic lavage samples or (b) be-
tween patients, potentially highlights the limitation of
predicting metabolic functions rather than utilising the
more costing metagenomic sequencing option. This lack
of difference could be a limitation of PICRUSt due to in-
formation only being available on a relatively limited
number of species or that sample types did have similar
metabolic functions. Unfortunately, until metagenomics
become more affordable for such studies, inferred meta-
bolic function will remain a favourable analysis strategy.
One of the main issues to comparing faecal and biopsy
microbial diversity is determining when to collect the
faecal sample in relation to the colonoscopy sampling to
ensure the most appropriate comparisons are made. The
benefit of our study was that we were able to sample
biopsy and colonic lavage simultaneously thus ensuring
an effective representation of community structure de-
void of sampling time bias.
The results presented here highlight the emerging
concept of the importance of managing potential con-
taminating sequences—especially in low biomass sam-
ples, which are introduced through the analysis pipeline.
Within our study, colonic mucosal biopsies were low
biomass samples and therefore more likely to be influ-
enced by contaminating bacteria from laboratory re-
agents [26]. In attempt to control this, we processed and
sequenced negative controls as well as PCR processing
samples in a random order to ensure avoiding creating
false patterns. Biopsies and colonic lavage samples were
also extracted using the same DNA extraction kit
batches to reduce potential contamination. On this basis,
although there is the possibility that these 14 differen-
tially expressed OTUs could be experimentally intro-
duced contaminants, consideration should also be given
to biological plausibility of some sequences [43]. The
various Firmicutes species that are routinely detected in
gut microbiota studies including Blautia and Lachnos-
praceae sequences potentially demonstrate species that
have a higher propensity for attachment to the colonic
mucosa and therefore a biologically plausible justifica-
tion is available. Other less common species including
Comomonadaceae, Staphylococcaceae and Propionibac-
teriaceae are more challenging to explain and have actu-
ally been highlighted to be associated with Qiagen DNA
extraction kits [26]. Thirty-four out of the 277 genera in
our analysed dataset were classified as possible contam-
inant genera, consisting of 0.94% of the total analysed
sequences. This small amount indicates that contamin-
ation is not a significant issue within biopsy or lavage
samples. However, higher presence of these potential
contaminants was detected within biopsy samples, this
indicates lavage samples are less affected by contamin-
ation, most likely due to the larger biomass available.
Conclusions
Although colonic biopsies will always give the best rep-
resentation of the bacterial communities that reside and
interact at the gut mucosa, the amount of microbial
DNA that can be harnessed is limited and potentially in-
sufficient for certain study types including metagenomic
studies or multiple analysis modalities [29]. Our data
demonstrates that at least for studies assessing the gut
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microbiome in prepped patient samples, colonic lavage
provides a comparable sample type in terms of gut
microbiota community structure but also yields signifi-
cantly higher amounts of material for multiple analyses.
It is appreciated that faecal sample collection still offers
the benefit of participants not needing to have a colon-
oscopy to provide samples and therefore attracting large
sample size is not an issue. However, there remains the
issue of ensuring faecal sample collection approaches ef-
fectively retain microbial community structure through
collection and processing which is always challenging in
patient-led sample collection. Colonic lavage offers the
benefit of sample size that faecal samples provide but
from a controllable collection protocol.
Methods
Subject recruitment
Study participants were recruited from subjects who had
presented for screening colonoscopy as part of the na-
tional colorectal cancer screening but were subsequently
confirmed to have no macroscopic or microscopic colonic
pathology after endoscopic and histological examination.
An approach with study information was made by post in
advance of admission. Patients were excluded if they re-
ceived systemic antibiotics 3 months prior to their colon-
oscopy. All patients received bowel preparation prior to
colonoscopy (Picolax) following a standardised protocol
given to all colorectal cancer screening participants. Bowel
preparation was good in all subjects in the study.
Sample collection
Patients received bowel preparation the day before the
procedure in the form of Picolax (Ferring Pharmaceuti-
cals). This laxative has two active ingredients: sodium
picosulfate and magnesium citrate. The former is a
stimulant laxative and the latter is an osmotic laxative.
The preparation comes in powder form which is recon-
stituted in 150 ml of cold water before ingestion, and
the usual dose is two sachets taken 6 hours apart the
day prior to the colonoscopy. The patients are encour-
aged to drink as much clear fluids as possible on the day
prior to the procedure to flush the bowel out. Colonic
lavage samples (5 ml per patient, from the sigmoid colon
and without contamination by solid faeces) were aspi-
rated from the bowel at the time of colonoscopy using a
suction trap, transferred to a separate tube and immedi-
ately snap-frozen in liquid nitrogen before being trans-
ferred to −80 °C freezer. Biopsies were collected from
the sigmoid colon during colonoscopy using standard
endoscopic forceps (Boston Scientific Nanterre Cedex,
France). Pinch biopsies were either fixed for histological
assessment or placed directly into a 1.5-ml Eppendorf
tube and snap-frozen in liquid nitrogen and transferred
to a −80 °C freezer until further analysis.
DNA extraction
Genomic DNA was extracted from the colonic mucosal
biopsies, two per patient, and colonic lavage samples
using the commercially available QIAamp DNA Mini Kit
(Qiagen, Crawley, UK) using minor modifications of the
manufacturer’s instructions, as previously described which
included the addition of 10 μl of Proteinase K during the
initial lysis period of 18 hours to ensure complete lysis of
the biopsy material prior to DNA extraction [44].
PCR amplification and sequencing
The V1-2 region of the 16S rRNA gene was amplified
using 27 F and 338R primers. The primers were designed
with the Illumina adapter overhang already included.
Amplification was performed using the Q5 polymerase kit
following the manufacturer’s instructions (New England
Bio, Ipswich, MA, USA). Post-amplification, samples were
purified using AMPure XP (Beckman Coulter, Brea, Cali-
fornia, USA) according to manufacturer protocol. The
samples were then indexed using the Nextera XT Index
Kit V2 (Illumina, San Diego, CA, USA) and KAPA HiFi
Hotstart ReadyMix (Kapa Biosystems, Cape Town, South
Africa) with a short cycle PCR step followed by a clean-up
with AMPure XP. The libraries were quantified using
Quant-iT™ dsDNA Assay Kit HS (Thermo Fisher Scien-
tific, Waltham, MA, USA) and analysed on a FLUOstar
Omega plate reader (BMG LABTECH, Ortenberg,
Germany). The library size was determined using the
Agilent 2200 TapeStation (Agilent Technologies, Santa
Clara, CA, USA). The libraries were pooled at equimo-
lar concentrations in preparation for sequencing.
Sequencing was performed using an Illumina MiSeq
sequencer (Illumina, San Diego, CA, USA) using Illumina
V3 chemistry and paired-end 2 × 300 base pair reads. All
sequencing was performed in a single MiSeq run. Initial
sequence data processing was performed by the Illumina
MiSeq Reporter to de-multiplex samples and remove
adapter and primer sequences sequence data was exported
in the FASTQ format. Sequencing was performed within
the Centre for Genome Enabled Biology and Medicine,
University of Aberdeen.
Bioinformatics analysis
The 16S rRNA gene sequence data was further proc-
essed using mothur [45] following the MiSeq SOP, which
was first accessed in February 2015 [46]. A full record of
sequence QC and analysis code carried out with mothur
is contained within Additional file 11. The total number
of raw paired read sets was 5,396,032 with a mean number
of sets of paired reads per sample of 117305.04. After
quality control, the samples had a minimum of 11879
reads and mean of 60886, and a mean sequence length of
451 bases with a 2.5 and 95.5 percentile lengths of 440
and 465 bases, respectively.
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Alignment and classification were done against the
SILVA v119 reference set [47]. Diversity was assessed
using the inverse Simpson index [48]. Alpha and beta di-
versity metrics, Observed OTUs, Chao, Shannon, inverse
Simpson, Coverage and Jaccard and Yue & Clayton were
calculated using the average score of 1000 random sub-
samples of the OTUs of each bacterial community to
11000 sequences per sample. These calculations (apart
from Chao and Shannon) are the calculations used in
the OTU-based analysis section of the Mothur MiSeq
SOP [45]. Community structures were compared using
PCoA plots generated using the Jaccard and Yue & Clay-
ton distance metrics. PCoA plots were compared with
AMOVA within mothur. LefSe was carried on an OTU
table subsampled to 11000 sequences per community
within mothur [28]. Subsequent statistical analysis was
done in R 3.2.2 [49].
Prior to PICRUSt analysis, mothur-produced OTUs
were classified with GreenGenes (August 2013 release of
gg_13_8_99) [50]. Metagenome functional content was
predicted using PICRUSt [27]. The predicted KEGG
orthologs were collapsed into KEGG pathways. Alpha
and Beta diversity metrics, Observed KEGGs, Chao,
Shannon, inverse Simpson, Coverage and Jaccard and
Yue & Clayton were calculated using the average score
of 1000 random subsamples of the OTUs of each bacter-
ial community to 500000 KEGG orthologs per sample.
LefSe was carried out on the KEGG pathway table nor-
malised to a sum of 1 million orthologs per sample.
Figures were created using R and various R packages.
Additional file 12 contains a full record of the figure
production carried out in R, this record was created by
the R package knitr [51]. Rarefaction plot, alpha diver-
sity plots, taxa pie charts, taxa bar charts and LDA
scores figures were created using the ggplot, geom_box-
plot, geom_bar and other various functions from the
ggplot2 package [52]. Heat maps were constructed
using the heatmap.2 function from the gplots package
[53]. Correlation plots were produced using the corrplot
function from the corrplot package [54]. Colour palettes
from the R package RColorBrewer were used within plots
[55]. Assessment of hierarchical clustering was carried out
using the pvclust and pvrect functions from the pyclust
package [56]. Hierarchical clustering in the heat maps
and hierarchical assessment were carried out using Eu-
clidean distances with complete hierarchical clustering.
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